Can’t sleep. Can’t believe it’s real.
Jaylen Brown is really a Philadelphia 76er… NBA Finals MVP, Jaylen Brown. That dude. Boston traded him to us for pennies on the dollar.
Please enjoy 10 minutes of last seasons highlights. Welcome to Philly @FCHWPO.
@PompeyOnSixers The Knicks are showing that chemistry, competitiveness, and consistency are keys to championship run- not changing lineups every other game!
Presented at #ASCO26:
In relapsed multiple myeloma, teclistamab improved 18-month progression-free survival as compared with standard therapy. Grade 3 or 4 infections were common; antimicrobial prophylaxis and immune globulin support were recommended. Full phase 3 MajesTEC-9 trial results: https://t.co/SIvjV5K7ED
Editorial: Redefining Early Relapse in Multiple Myeloma — Time to Change the Rules https://t.co/OBwZ4FxVe1
@ASCO
The thought of seeing Joel Embiid wear another teams uniform is not one I like…
Is he perfect? Of course not, his body has failed him over & over. But I’m rocking with @JoelEmbiid until he calls it a career & I hope that’s in Philly
The most talented/under appreciated big ever
People often ask how breakthroughs occur in cancer biology-often the story is more complex - the survival plot for myeloma outcomes is extraordinary - improvements come about in incremental steps - in my lifetime treatment of Myeloma has almost transformed into a curable disease
Excited to see the approval for #MajesTEC3. #MyCompany
I appreciate the @FoodDrugAdmin Commissioner’s quote: “Multiple myeloma is notoriously challenging to treat. When we saw the most impressive second-line myeloma trial results in history, we acted quickly to bring this finding to everyday Americans wrestling with the disease.”
https://t.co/sTDXPfM4RP
BREAKING: Music legend Bruce Springsteen just released this incredible song that will be sure to piss Trump off beyond belief.
“Streets of Minneapolis”.
He wrote this song about Alex Pretti and Renée Good Saturday and recorded it yesterday.
Share it far and wide and play it as loud as you can
In @CoMMitTrials we are testing Tec-Dara as consolidation-maintenance, fixed duration, steroid free. Hoping to prevent progression from happening in first place. @MyelomaTeacher@grpetersen1
Presented at #ASH25:
In untreated chronic lymphocytic leukemia, fixed-duration venetoclax-based regimens were noninferior to continuous ibrutinib with regard to 3-year progression-free survival and were associated with higher MRD-negative rates. Full CLL17 phase 3 trial results: https://t.co/MnlUxXBGrx
@ASH_hematology
Results published today in @NEJM underscore our determination @JNJInnovMed to push the boundaries of science and improve the treatment of EGFR-mutated non-small cell lung cancer.
https://t.co/4wMpGbwetD
#MyCompany#JNJOncology